Modern Chinese Medicine Group Co., Ltd. (HKG:1643)
1.110
-0.050 (-4.31%)
Feb 13, 2026, 3:57 PM HKT
HKG:1643 Revenue
Modern Chinese Medicine Group had revenue of 64.76M CNY in the half year ending June 30, 2025, a decrease of -64.04%. This brings the company's revenue in the last twelve months to 202.20M, down -15.96% year-over-year. In the year 2024, Modern Chinese Medicine Group had annual revenue of 214.07M, down -37.78%.
Revenue (ttm)
202.20M CNY
Revenue Growth
-15.96%
P/S Ratio
3.61
Revenue / Employee
1.06M CNY
Employees
190
Market Cap
799.20M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 214.07M | -130.01M | -37.78% |
| Dec 31, 2023 | 344.08M | -55.58M | -13.91% |
| Dec 31, 2022 | 399.66M | 38.96M | 10.80% |
| Dec 31, 2021 | 360.70M | 52.00M | 16.85% |
| Dec 31, 2020 | 308.69M | 89.93M | 41.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 38.69B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| EC Healthcare | 4.01B |
| Lee's Pharmaceutical Holdings | 1.44B |
| Xikang Cloud Hospital Holdings | 548.86M |
| Pak Fah Yeow International | 199.55M |